Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)

( DrugBank: Daratumumab / KEGG DRUG: Daratumumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
28	全身性アミロイドーシス	17

28. 全身性アミロイドーシス

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

trials per page:

Showing 1 to 10 of 17 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-002639-48-DE (EUCTR)	25/07/2022	15/12/2021	A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants withAmyloid Light Chain ...	A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants withAmyloid Light Chain ...	Amyloid Light Chain Amyloidosis MedDRA version: 23.0;Level: LLT;Classification code 10083938;Term: A ...	Trade Name: DAZARLEX Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rH ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 2	France;United States;Greece;Canada;Spain;Netherlands;Germany;United Kingdom;Italy
2	EUCTR2021-002639-48-NL (EUCTR)	10/06/2022	09/02/2022	A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants withAmyloid Light Chain ...	A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants withAmyloid Light Chain ...	Amyloid Light Chain Amyloidosis MedDRA version: 23.0;Level: LLT;Classification code 10083938;Term: A ...	Trade Name: DAZARLEX Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rH ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 2	United States;France;Greece;Canada;Spain;Germany;Netherlands;United Kingdom;Italy
3	EUCTR2021-002639-48-ES (EUCTR)	08/03/2022	28/12/2021	A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants withAmyloid Light Chain ...	A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants withAmyloid Light Chain ...	Amyloid Light Chain Amyloidosis MedDRA version: 23.0;Level: LLT;Classification code 10083938;Term: A ...	Trade Name: DAZARLEX Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rH ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 2	France;United States;Greece;Canada;Spain;Netherlands;Germany;United Kingdom;Italy
4	EUCTR2018-004333-33-FR (EUCTR)	23/01/2020	02/12/2019	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Patients withnewly diagnosed stage 3B AL amyloidosis MedDRA version: 20.0;Level: PT;Classification c ...	Trade Name: Velcade Product Name: Bortezomib Product Code: 26866138 INN or Proposed INN: BORTEZOMIB Prod ...	European Myeloma Network	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	France;Greece;Netherlands;Italy
5	EUCTR2018-004333-33-IT (EUCTR)	01/08/2019	28/04/2020	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Patients withnewly diagnosed stage 3B AL amyloidosis MedDRA version: 20.0;Level: PT;Classification c ...	Trade Name: Darzalex Product Name: Daratumumab Product Code: JNJ-54767414 INN or Proposed INN: DARATUMU ...	European Myeloma Network	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	France;Greece;Netherlands;Italy
6	EUCTR2018-004333-33-NL (EUCTR)	24/07/2019	08/07/2019	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Patients withnewly diagnosed stage 3B AL amyloidosis MedDRA version: 20.0;Level: PT;Classification c ...	Trade Name: Darzalex Product Name: Daratumumab Product Code: JNJ-54767414 INN or Proposed INN: DARATUMU ...	European Myeloma Network	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	France;Greece;Netherlands;Italy
7	EUCTR2018-004333-33-GR (EUCTR)	08/07/2019	05/06/2019	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Phase 2 study of daratumumabmonotherapy in previously untreated patients withstage 3B light chain (A ...	Patients withnewly diagnosed stage 3B AL amyloidosis MedDRA version: 20.0;Level: PT;Classification c ...	Trade Name: Darzalex Product Name: Daratumumab Product Code: JNJ-54767414 INN or Proposed INN: DARATUMU ...	European Myeloma Network	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	France;Greece;Netherlands;Italy
8	EUCTR2016-001737-27-GB (EUCTR)	08/10/2018	11/01/2018	A Study to Evaluate the Efficacy and Safety of Daratumumabin Combination WithCyclophosphamide, Borte ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumabin Combination withCycl ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...
9	EUCTR2016-001737-27-PL (EUCTR)	06/09/2018	16/07/2018	A Study to Evaluate the Efficacy and Safety of Daratumumabin Combination WithCyclophosphamide, Borte ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumabin Combination withCycl ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;United Kingdom;Italy;France;Hungary;Mexico;Canada;Belgium;P ...
10	EUCTR2016-001737-27-DK (EUCTR)	22/08/2018	04/06/2018	A Study to Evaluate the Efficacy and Safety of Daratumumabin Combination WithCyclophosphamide, Borte ...	A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumabin Combination withCycl ...	AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis ) MedDRA version: 20.0;Level: PT;Classificat ...	Product Name: Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) Product Code: ...	Janssen-Cilag International N.V.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	370	Phase 3	United States;Greece;Spain;Turkey;Israel;Italy;United Kingdom;France;Hungary;Mexico;Canada;Poland;Be ...

First Previous1 2Next Last